Here are Antti’s comments regarding the new deal 
Nightingale Health announced on Wednesday that it has signed a service agreement with Archipelago Health to bring its test to the British Crown Dependencies, Bermuda, and the Caribbean. The news is an expected follow-up step to the letter of intent published in July and demonstrates the company’s ability to advance negotiations swiftly to a commercial phase. We view the expansion into new geographical areas as positive, but as with previous initial breakthroughs, we estimate that the early-stage volumes and thus the immediate financial significance of the agreement will remain limited. Therefore, the news does not cause changes to our forecasts, but it partly supports our expectations of strong growth in the coming years.